Lei Shi

机构：Beijing University of Chinese Medicine, Shanghai Drug Administration, China Agricultural University · ORCID：0000-0002-7925-5166

发表论文 34 篇 · 总被引 602 次 · h-index 13

代表论文

• Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019 (2022 · Frontiers in Public Health · 被引 150)
• Gut microbiota-derived 12-ketolithocholic acid suppresses the IL-17A secretion from colonic group 3 innate lymphoid cells to prevent the acute exacerbation of ulcerative colitis (2023 · Gut Microbes · 被引 61)
• Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review (2023 · Frontiers in Pharmacology · 被引 52)
• Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis (2020 · Medicine · 被引 37)
• Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses (2020 · World Journal of Gastroenterology · 被引 36)
• Inhibition of human and rat placental 3β-hydroxysteroid dehydrogenase/Δ5,4-isomerase activities by insecticides and fungicides: Mode action by docking analysis (2022 · Chemico-Biological Interactions · 被引 24)